Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
MyChesCo on MSN18h
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease
Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...
The Berkshire Edge6h
THE OTHER SIDE: RFK Jr.’s war on public health
It is one thing to ignore the easily found evidence of the effectiveness of vaccination, but it is incredibly worse and ...
Open-source AI matches top proprietary model in solving tough medical cases
Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide ...
Decentralized science meets AI — legacy institutions aren’t ready
The combination of DeSci and AI could transform scientific research, challenging traditional funding, publishing and ...
Sanofi: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...